Profund Advisors
PDLI

Profund Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Profund Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-129,120
Closed -$830K – 1493
2015
Q2 		$830K Sell
129,120
-143
-0.1% -$958 0.03% 487
2015
Q1 		$909K Buy
129,263
+10,166
+9% +$73.6K 0.04% 535
2014
Q4 		$918K Buy
119,097
+12,746
+12% +$101K 0.04% 486
2014
Q3 		$794K Sell
106,351
-1,314
-1% -$12.2K 0.04% 478
2014
Q2 		$1.04M Sell
107,665
-8,587
-7% -$76.5K 0.05% 456
2014
Q1 		$966K Buy
116,252
+24,335
+26% +$209K 0.04% 486
2013
Q4 		$776K Buy
91,917
+18,936
+26% +$160K 0.03% 698
2013
Q3 		$582K Buy
72,981
+2,269
+3% +$18.2K 0.03% 817
2013
Q2 		$546K Buy
+70,712
New +$551K 0.04% 573

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Gotham Asset Management
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Profund Advisors's PDLI Position: Q3 2015 in Review

Profund Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q3 2015, closing a stake of 129,120 shares — an estimated $830K sold.

Profund Advisors first reported a position in PDLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.04M in Q2 2014. 213 funds tracked by Wall St. Rank hold PDLI as of Q3 2015.

  • Profund Advisors reported no remaining PDL BioPharma, Inc. position as of Q3 2015 after selling out during the quarter.
  • Profund Advisors sold 129,120 PDL BioPharma, Inc. shares in Q3 2015, an estimated $830K.
  • Profund Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 9 quarters.
  • Profund Advisors's PDL BioPharma, Inc. position peaked at $1.04M in Q2 2014.
  • 213 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2015.

Based on Profund Advisors's 13F filing for Q3 2015, filed 6 Nov 2015.